Literature DB >> 7392945

Celiac disease and malignancy.

B T Cooper, G K Holmes, R Ferguson, W T Cooke.   

Abstract

Fifty-five patients with celiac disease and coexistent malignant disease (27 lymphoma, 28 other malignancies) are described. The important clinical features at presentation of lymphoma were weight loss, abdominal pain, diarrhea, profound weakness and fever, associated with anemia, raised ESR, hypoalbuminemia and steatorrhea. There were no specific features to enable earlier diagnosis. Radiology was unhelpful and in no case were malignant cells seen in the jejunal biopsy. Four of the lymphomas were Hodgkin's disease, none of which involved the bowel; the remainder were reticulum cell sarcoma, 17 of which involved the bowel. Definitive diagnosis prior to death was made in only 18 patients, of whom 16 survived from 2 to 226 days (mean, 76 days). Of the remaining two patients, one is still alive, while the other died 26 years after the original diagnosis of Hodgkin's disease. The possibility of lymphoma should be considered in those who present with celiac disease in middle life and in those who deteriorate for no apparent reason after a period of stability on a gluten-free diet. The index of suspicion for lymphoma in celiac disease should be high and early laparotomy be considered in patients with unexplained deterioration. Twenty-eight patients with 29 carcinomas and 3 other tumors are also described. The presentations of these malignancies were no different from their presentations in non-celiac patients, and their development did not provoke a relapse of celiac disease. Considering the whole series of 55 patients, there was little evidence for the view that malignancy itself was the cause of the flat jejunal mucosal appearances seen in these patients.

Entities:  

Mesh:

Year:  1980        PMID: 7392945     DOI: 10.1097/00005792-198007000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  32 in total

1.  Celiac sprue among US military veterans: associated disorders and clinical manifestations.

Authors:  F Delcò; H B El-Serag; A Sonnenberg
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Somatostatinoma of the ampulla of vater in celiac sprue.

Authors:  E J Frick; J R Kralstein; M Scarlato; H C Hoover
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

3.  Coeliac disease and disseminated lymphomatosis.

Authors:  M K Kulshrestha; W P Honan; N Aluwihare; M Carey; R N Allan
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

Review 4.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 5.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

6.  Compliance of adolescents with coeliac disease with a gluten free diet.

Authors:  M Mayer; L Greco; R Troncone; S Auricchio; M N Marsh
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 7.  Carcinoma of the right side of the colon and celiac disease.

Authors:  I Casserly; F M Stevens; C F McCarthy
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

8.  Epstein-Barr virus specific antibodies in patients with coeliac disease.

Authors:  S Harada; J Greally; J Davis; N Synder; F Stevens; C McCarthy; D T Purtilo
Journal:  Ir J Med Sci       Date:  1985-11       Impact factor: 1.568

9.  Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

Authors:  K E Smedby; M Akerman; H Hildebrand; B Glimelius; A Ekbom; J Askling
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

10.  Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease.

Authors:  S O Ukabam; B T Cooper
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.